methionine has been researched along with sulfinpyrazone in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (66.67) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Casonato, A; Fabris, F; Girolami, A; Randi, ML; Schiavinato, L; Schivazappa, L | 1 |
Dahinden, C; Fehr, J | 1 |
1 trial(s) available for methionine and sulfinpyrazone
Article | Year |
---|---|
Failure of sulphinpyrazone to affect platelet survival in patients with rheumatic heart valvular disease: a double blind study using 75Se-methionine labeled platelets.
Topics: Adult; Blood Platelets; Cell Survival; Clinical Trials as Topic; Combined Modality Therapy; Double-Blind Method; Female; Heart Valve Prosthesis; Humans; Male; Methionine; Middle Aged; Radioisotopes; Rheumatic Heart Disease; Selenium; Sulfinpyrazone; Thromboembolism | 1983 |
2 other study(ies) available for methionine and sulfinpyrazone
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Receptor-directed inhibition of chemotactic factor-induced neutrophil hyperactivity by pyrazolon derivatives. Definition of a chemotactic peptide antagonist.
Topics: Agranulocytosis; Arachidonic Acids; Aspirin; Cell Adhesion; Chemotactic Factors; Chemotaxis, Leukocyte; Dose-Response Relationship, Drug; Humans; Indomethacin; Methionine; N-Formylmethionine; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Oligopeptides; Phenylbutazone; Sulfinpyrazone | 1980 |